IRVINE, Calif. – Oventus Medical has reported interim financial results for the six months ended Dec. 31, 2021, including $554,000 in revenue. The company, which makes the O2Vent oral device to treat ...

Brisbane, July 12, 2017 AEST (ABN Newswire) - Australian medical device company, Oventus Medical Ltd. (ASX:OVN) has received FDA 510k clearance for its O2Vent W device, an oral appliance intended to ...

Brisbane, May 5, 2017 - (ABN Newswire) - Australian medical device company Oventus Medical Ltd. (ASX:OVN), has lodged an FDA 510k submission for its O2Vent W device - an oral appliance intended to ...

Oventus Medical Ltd (ASX:OVN) is pleased to announce the Canadian launch of the O2Vent (R) Optima device which treats both the potentially fatal condition, obstructive sleep apnoea and snoring. The ...

Sleep apnoea devices manufacturer Oventus Medical has listed on the Australian Securities Exchange (ASX) after raising AU$12 million. In partnership with the Commonwealth Scientific and Industrial ...

Australia-based medical device company Oventus Medical will unveil its O2Vent flagship product in the US later this month to treat snoring and sleep apnoea. Cleared by the US Food and Drug ...

The O2Vent (R) Optima is a customised 3D printed nylon oral appliance that advances the jaw forward to open the airway and incorporates the Oventus proprietary Airway Technology to improve the ...

Medical device company Oventus Medical (ASX: OVN) has confirmed its sleep treatment platform will be included in a range of obstructive sleep apnoea (OSA) treatment solutions being sold by Aeroflow ...

Oventus Medical Ltd (ASX:OVN) is pleased to announce the Canadian launch of the O2Vent(R) Optima device which treats both the potentially fatal condition, obstructive sleep apnoea (OSA) and snoring.

Oventus Medical Ltd (ASX:OVN) is pleased to announce the launch of the O2Vent(R) Optima device in Australia, an important addition to the Company's sleep treatment platform. Key points: - New Oventus ...